摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

3-甲硫基-1,2,4-三嗪 | 28735-21-9

中文名称
3-甲硫基-1,2,4-三嗪
中文别名
——
英文名称
3-methylthio-1,2,4-triazine
英文别名
3-methylsulfanyl-1,2,4-triazine
3-甲硫基-1,2,4-三嗪化学式
CAS
28735-21-9
化学式
C4H5N3S
mdl
MFCD00490024
分子量
127.17
InChiKey
NFHGWQLAJYTULJ-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    33 °C
  • 沸点:
    275.8±23.0 °C(Predicted)
  • 密度:
    1.28±0.1 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    0
  • 重原子数:
    8
  • 可旋转键数:
    1
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.25
  • 拓扑面积:
    64
  • 氢给体数:
    0
  • 氢受体数:
    4

安全信息

  • 危险品标志:
    Xn
  • 危险类别码:
    R22
  • 危险性防范说明:
    P280,P305+P351+P338
  • 危险性描述:
    H302
  • 储存条件:
    2-8℃

SDS

SDS:670b9620626b7838bd7e0843bb47dda8
查看

SECTION 1: Identification of the substance/mixture and of the company/undertaking
Product identifiers
Product name : 3-(Methylthio)-2,4-Triazine
REACH No. : A registration number is not available for this substance as the substance
or its uses are exempted from registration, the annual tonnage does not
require a registration or the registration is envisaged for a later
registration deadline.
Relevant identified uses of the substance or mixture and uses advised against
Identified uses : Laboratory chemicals, Manufacture of substances



SECTION 2: Hazards identification
Classification of the substance or mixture
Classification according to Regulation (EC) No 1272/2008
Acute toxicity, Oral (Category 4), H302
For the full text of the H-Statements mentioned in this Section, see Section 16.
Classification according to EU Directives 67/548/EEC or 1999/45/EC
Xn Harmful R22
For the full text of the R-phrases mentioned in this Section, see Section 16.
Label elements
Labelling according Regulation (EC) No 1272/2008
Pictogram
Signal word Warning
Hazard statement(s)
H302 Harmful if swallowed.
Precautionary statement(s) none
Supplemental Hazard none
Statements
Other hazards
This substance/mixture contains no components considered to be either persistent, bioaccumulative and
toxic (PBT), or very persistent and very bioaccumulative (vPvB) at levels of 0.1% or higher.

SECTION 3: Composition/information on ingredients
Substances
Molecular weight : 127,17 g/mol
Hazardous ingredients according to Regulation (EC) No 1272/2008
Component Classification Concentration
3-(Methylthio)-2,4-Triazine
Acute Tox. 4; H302 <= 100 %
Hazardous ingredients according to Directive 1999/45/EC
Component Classification Concentration
3-(Methylthio)-2,4-Triazine
Xn, R22 <= 100 %
For the full text of the H-Statements and R-Phrases mentioned in this Section, see Section 16

SECTION 4: First aid measures
Description of first aid measures
General advice
Consult a physician. Show this safety data sheet to the doctor in attendance.
If inhaled
If breathed in, move person into fresh air. If not breathing, give artificial respiration. Consult a physician.
In case of skin contact
Wash off with soap and plenty of water. Consult a physician.
In case of eye contact
Flush eyes with water as a precaution.
If swallowed
Never give anything by mouth to an unconscious person. Rinse mouth with water. Consult a physician.
Most important symptoms and effects, both acute and delayed
The most important known symptoms and effects are described in the labelling (see section 2.2) and/or in
section 11
Indication of any immediate medical attention and special treatment needed
No data available

SECTION 5: Firefighting measures
Extinguishing media
Suitable extinguishing media
Use water spray, alcohol-resistant foam, dry chemical or carbon dioxide.
Special hazards arising from the substance or mixture
Nature of decomposition products not known.
Advice for firefighters
Wear self-contained breathing apparatus for firefighting if necessary.
Further information
No data available

SECTION 6: Accidental release measures
Personal precautions, protective equipment and emergency procedures
Use personal protective equipment. Avoid dust formation. Avoid breathing vapours, mist or gas. Ensure
adequate ventilation. Avoid breathing dust.
For personal protection see section 8.
Environmental precautions
Do not let product enter drains.
Methods and materials for containment and cleaning up
Pick up and arrange disposal without creating dust. Sweep up and shovel. Keep in suitable, closed
containers for disposal.
Reference to other sections
For disposal see section 13.

SECTION 7: Handling and storage
Precautions for safe handling
Avoid contact with skin and eyes. Avoid formation of dust and aerosols.
Provide appropriate exhaust ventilation at places where dust is formed.
For precautions see section 2.2.
Conditions for safe storage, including any incompatibilities
Store in cool place. Keep container tightly closed in a dry and well-ventilated place.
Storage class (TRGS 510): Non Combustible Solids
Specific end use(s)
Apart from the uses mentioned in section 1.2 no other specific uses are stipulated

SECTION 8: Exposure controls/personal protection
Control parameters
Components with workplace control parameters
Exposure controls
Appropriate engineering controls
Handle in accordance with good industrial hygiene and safety practice. Wash hands before breaks and
at the end of workday.
Personal protective equipment
Eye/face protection
Safety glasses with side-shields conforming to EN166 Use equipment for eye protection tested
and approved under appropriate government standards such as NIOSH (US) or EN 166(EU).
Skin protection
Handle with gloves. Gloves must be inspected prior to use. Use proper glove removal technique
(without touching glove's outer surface) to avoid skin contact with this product. Dispose of
contaminated gloves after use in accordance with applicable laws and good laboratory practices.
Wash and dry hands.
The selected protective gloves have to satisfy the specifications of EU Directive 89/686/EEC and
the standard EN 374 derived from it.
Body Protection
Complete suit protecting against chemicals, The type of protective equipment must be selected
according to the concentration and amount of the dangerous substance at the specific workplace.
Respiratory protection
For nuisance exposures use type P95 (US) or type P1 (EU EN 143) particle respirator.For higher
level protection use type OV/AG/P99 (US) or type ABEK-P2 (EU EN 143) respirator cartridges.
Use respirators and components tested and approved under appropriate government standards
such as NIOSH (US) or CEN (EU).
Control of environmental exposure
Do not let product enter drains.

SECTION 9: Physical and chemical properties
Information on basic physical and chemical properties
a) Appearance Form: solid
b) Odour No data available
c) Odour Threshold No data available
d) pH No data available
e) Melting point/freezing No data available
point
f) Initial boiling point and No data available
boiling range
g) Flash point No data available
h) Evaporation rate No data available
i) Flammability (solid, gas) No data available
j) Upper/lower No data available
flammability or
explosive limits
k) Vapour pressure No data available
l) Vapour density No data available
m) Relative density No data available
n) Water solubility No data available
o) Partition coefficient: n- No data available
octanol/water
p) Auto-ignition No data available
temperature
q) Decomposition No data available
temperature
r) Viscosity No data available
s) Explosive properties No data available
t) Oxidizing properties No data available
Other safety information
No data available

SECTION 10: Stability and reactivity
Reactivity
No data available
Chemical stability
Stable under recommended storage conditions.
Possibility of hazardous reactions
No data available
Conditions to avoid
No data available
Incompatible materials
Strong oxidizing agents
Hazardous decomposition products
In the event of fire: see section 5

SECTION 11: Toxicological information
Information on toxicological effects
Acute toxicity
No data available
Skin corrosion/irritation
No data available
Serious eye damage/eye irritation
No data available
Respiratory or skin sensitisation
No data available
Germ cell mutagenicity
No data available
Carcinogenicity
IARC: No component of this product present at levels greater than or equal to 0.1% is identified as
probable, possible or confirmed human carcinogen by IARC.
Reproductive toxicity
No data available
Specific target organ toxicity - single exposure
No data available
Specific target organ toxicity - repeated exposure
No data available
Aspiration hazard
No data available
Additional Information
RTECS: Not available
To the best of our knowledge, the chemical, physical, and toxicological properties have not been
thoroughly investigated.

SECTION 12: Ecological information
Toxicity
No data available
Persistence and degradability
No data available
Bioaccumulative potential
No data available
Mobility in soil
No data available
Results of PBT and vPvB assessment
This substance/mixture contains no components considered to be either persistent, bioaccumulative and
toxic (PBT), or very persistent and very bioaccumulative (vPvB) at levels of 0.1% or higher.
Other adverse effects
No data available

SECTION 13: Disposal considerations
Waste treatment methods
Product
Offer surplus and non-recyclable solutions to a licensed disposal company. Dissolve or mix the material
with a combustible solvent and burn in a chemical incinerator equipped with an afterburner and scrubber.
Contaminated packaging
Dispose of as unused product.

SECTION 14: Transport information
UN number
ADR/RID: - IMDG: - IATA: -
UN proper shipping name
ADR/RID: Not dangerous goods
IMDG: Not dangerous goods
IATA: Not dangerous goods
Transport hazard class(es)
ADR/RID: - IMDG: - IATA: -
Packaging group
ADR/RID: - IMDG: - IATA: -
Environmental hazards
ADR/RID: no IMDG Marine pollutant: no IATA: no
Special precautions for user
No data available

SECTION 15: Regulatory information
This safety datasheet complies with the requirements of Regulation (EC) No. 1907/2006.
Safety, health and environmental regulations/legislation specific for the substance or mixture
No data available
Chemical Safety Assessment
For this product a chemical safety assessment was not carried out

SECTION 16: Other information
Full text of H-Statements referred to under sections 2 and 3.
Acute Tox. Acute toxicity
H302 Harmful if swallowed.
Full text of R-phrases referred to under sections 2 and 3
Xn Harmful
R22 Harmful if swallowed.
Further information
Copyright 2014 Co. LLC. License granted to make unlimited paper copies for internal use
only.
The above information is believed to be correct but does not purport to be all inclusive and shall be
used only as a guide. The information in this document is based on the present state of our knowledge
and is applicable to the product with regard to appropriate safety precautions. It does not represent any
guarantee of the properties of the product. Corporation and its Affiliates shall not be held
liable for any damage resulting from handling or from contact with the above product. See
and/or the reverse side of invoice or packing slip for additional terms and conditions of sale.

制备方法与用途

产品描述:3-甲硫基-1,2,4-三嗪是一种有机化合物,常被用作有机合成的中间体。

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    3-甲硫基-1,2,4-三嗪间氯过氧苯甲酸 作用下, 以90%的产率得到3-(甲基磺酰基)-1,2,4-三嗪
    参考文献:
    名称:
    1,2,4-三嗪的进一步分子内反应。呋喃并[2,3- ]吡啶和二氢吡喃并[2,3- ]吡啶的合成
    摘要:
    3-(3-丁炔氧基)-和3-(4-戊氧基)-1,2,4-三嗪容易发生分子内Diels-Alder反应,生成2,3-二氢呋喃(2,3- )吡啶和二氢吡喃(2, 3- )吡啶。前者很容易用DDQ脱氢为呋喃(2,3- )吡啶。
    DOI:
    10.1016/s0040-4039(00)85497-0
  • 作为产物:
    描述:
    S-甲基异硫氨基脲盐酸盐碳酸氢钠 作用下, 以 为溶剂, 反应 18.0h, 以93%的产率得到3-甲硫基-1,2,4-三嗪
    参考文献:
    名称:
    使用统一路线合成 3-(烷基氨基)-、3-(烷氧基)-、3-(芳氧基)-、3-(烷硫基)-和 3-(芳硫基)-1,2,4-三嗪3-(甲基磺酰基)-1,2,4-三嗪
    摘要:
    在我们尝试合成 3-(烷硫基)-和 3-(烷氧基)-1,2,4-三嗪时,在 5-或 6-位没有取代基,合成它们预期的前体 3-(甲基磺酰基)-1, 2,4 三嗪也进行了优化。探索了 3-(甲基磺酰基)-1,2,4-三嗪对烷基和芳基硫醇、伯和仲烷基胺、酚和醇的反应性,并对反应进行了优化,以最大限度地分离相应的 3-取代 1 ,2,4-三嗪。通过使用碱金属碳酸盐,与除醇之外的所有上述亲核试剂的反应产物获得了良好的产率。通过使用合适的醇镁作为亲核试剂获得更高产率的 3-(烷氧基)-1,2,4-三嗪。
    DOI:
    10.1002/ejoc.201600267
点击查看最新优质反应信息

文献信息

  • Easy Access to 3- or 5-Heteroarylamino-1,2,4-triazines by S<sub>N</sub>Ar, S<sub>N</sub><sup>H</sup>, and Palladium-Catalyzed N-Heteroarylations
    作者:Ethel Garnier、Jérôme Audoux、Eric Pasquinet、Franck Suzenet、Didier Poullain、Bruno Lebret、Gérald Guillaumet
    DOI:10.1021/jo0490898
    日期:2004.11.1
    In this paper, N-arylations between two heteroaryl compounds were studied. Conditions were found to generate selectively either 3- or 5-heteroarylamino-1,2,4-triazines by investigating anionic processes (use of bases such as 2,2‘,6,6‘-tetramethylpiperidine/tBuOK/nBuLi) or Pd-catalyzed N-arylations [Pd(OAc)2, xantphos]. These methods were successfully applied to a wide variety of heteroarylamines and
    本文研究了两个杂芳基化合物之间的N-芳基化作用。通过研究阴离子过程(使用碱,例如2,2',6,6'-四甲基哌啶/ t BuOK / n BuLi)发现条件可选择性生成3-或5-杂芳基氨基-1,2,4-三嗪。Pd催化的N-芳基化[Pd(OAc)2,xantphos]。这些方法已成功应用于多种杂芳基胺,使我们能够继续进行熔融多氮化合物合成的研究。
  • [EN] HERBICIDAL PYRIDINIUM COMPOUNDS<br/>[FR] COMPOSÉS DE PYRIDINIUM HERBICIDES
    申请人:SYNGENTA CROP PROTECTION AG
    公开号:WO2020161162A1
    公开(公告)日:2020-08-13
    Compounds of the formula (I) wherein the substituents are as defined in claim 1, useful as a pesticides, especially as herbicides.
    式(I)中的化合物,其中取代基如权利要求1中定义的那样,作为杀虫剂特别是除草剂有用。
  • [EN] CYCLOHEXYL ACID TRIAZOLE AZINES AS LPA ANTAGONISTS<br/>[FR] AZINES TRIAZOLES D'ACIDE CYCLOHEXYLE UTILISÉES EN TANT QU'ANTAGONISTES DE LPA
    申请人:BRISTOL MYERS SQUIBB CO
    公开号:WO2019126093A1
    公开(公告)日:2019-06-27
    The present invention provides compounds of Formula (I): Formula (I) or a stereoisomer, tautomer, or pharmaceutically acceptable salt or solvate thereof, wherein all the variables are as defined herein. These compounds are selective LPA receptor inhibitors.
    本发明提供了化合物的结构式(I):结构式(I)或其立体异构体、互变异构体或药学上可接受的盐或溶剂,其中所有变量如本文所定义。这些化合物是选择性LPA受体抑制剂。
  • Intramolecular Inverse Electron Demand Diels–Alder Reactions of Tryptamine with Tethered Heteroaromatic Azadienes
    作者:Scott C. Benson、Lily Lee、Lydie Yang、John K. Snyder
    DOI:10.1016/s0040-4020(00)00003-x
    日期:2000.2
    1,2,4,5-Tetrazines and 1,2,4-triazines tethered to tryptamine via the ethylamine side chain undergo intramolecular inverse electron demand cycloadditions to produce adducts with the [ABazaCE]-ring skeleton of the Aspidosperma alkaloids.
    通过乙胺侧链束缚在色胺上的1,2,4,5-四嗪和1,2,4-三嗪经历分子内逆电子需量环加成反应,生成了具有白色胚芽孢生物碱的[ABazaCE]环骨架的加合物。
  • 1,2,4-Triazines in the Synthesis of Bipyridine Bisphenolate ONNO Ligands and Their Highly Luminescent Tetradentate Pt(II) Complexes for Solution-Processable OLEDs
    作者:Piotr Pander、Rachel Bulmer、Ross Martinscroft、Stuart Thompson、Frank W. Lewis、Thomas J. Penfold、Fernando B. Dias、Valery N. Kozhevnikov
    DOI:10.1021/acs.inorgchem.7b03175
    日期:2018.4.2
    rings. The new ligands were used to prepare highly luminescent ONNO-type Pt(II) complexes. The position of the cyclopentene rings significantly influences the solubility and photophysical properties of these complexes. Derivatives with closely positioned cyclopentene rings are soluble in organic solvents and proved to be the best candidate for solution-processable organic light-emitting devices (OLEDs)
    本文介绍了一种方便的合成ONNO型四齿6,6'-双(2-苯氧基)-2,2'-联吡啶(联吡啶双酚盐,BpyBph)配体及其铂(II)配合物的方法。该方法包括合成1,2,4-三嗪前体,然后通过Boger反应将其转化为官能化的吡啶。使用3,3′-和5,5′-双三嗪的两个互补途径允许中心吡啶环在不同位置上的修饰,这通过引入环戊烯环来举例说明。新的配体用于制备高发光度的ONNO型Pt(II)配合物。环戊烯环的位置显着影响这些配合物的溶解度和光物理性质。
查看更多

表征谱图

  • 氢谱
    1HNMR
  • 质谱
    MS
  • 碳谱
    13CNMR
  • 红外
    IR
  • 拉曼
    Raman
查看更多图谱数据,请前往“摩熵化学”平台
查看更多图谱数据,请前往“摩熵化学”平台
cnmr
查看更多图谱数据,请前往“摩熵化学”平台
查看更多图谱数据,请前往“摩熵化学”平台
  • 峰位数据
  • 峰位匹配
  • 表征信息
Shift(ppm)
Intensity
查看更多图谱数据,请前往“摩熵化学”平台
Assign
Shift(ppm)
查看更多图谱数据,请前往“摩熵化学”平台
测试频率
样品用量
溶剂
溶剂用量
查看更多图谱数据,请前往“摩熵化学”平台